scispace - formally typeset
C

Chun Hei Antonio Cheung

Researcher at National Cheng Kung University

Publications -  58
Citations -  8227

Chun Hei Antonio Cheung is an academic researcher from National Cheng Kung University. The author has contributed to research in topics: Survivin & Cancer cell. The author has an hindex of 25, co-authored 53 publications receiving 6665 citations. Previous affiliations of Chun Hei Antonio Cheung include University of Auckland & National Health Research Institutes.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Treat cancers by targeting survivin: Just a dream or future reality?

Mohane Selvaraj Coumar, +4 more
- 01 Nov 2013 - 
TL;DR: Despite the growing amount of knowledge related to survivin in the last ten years, the development of survivin inhibitors or survivin-related molecular therapies is surprisingly and relatively slow as compared to other therapeutic inhibitors for cancer treatment.
Journal ArticleDOI

Survivin - biology and potential as a therapeutic target in oncology.

Chun Hei Antonio Cheung, +8 more
- 16 Oct 2013 - 
TL;DR: In this review, the complex expression regulations and post-translational modifications of survivin are discussed and how recent discoveries improve the understanding ofsurvivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy.
Journal ArticleDOI

Aurora kinase inhibitors in preclinical and clinical testing

Chun Hei Antonio Cheung, +3 more
- 01 Apr 2009 - 
TL;DR: Considering the fact that aurora kinase plays an important role in the mitosis process and is involved in tumorigenesis, development of aurora Kinase inhibitors for the treatment of cancer, either as a single agent or in combination with existing cancer treatment is warranted.